Cosmos Holdings Competitors and Similar CompaniesClear all
Cosmos Holdings's competitors and similar companies include Kadmon, Lee's Pharm, Sino Biopharmaceutical and Duopharma Biotech.
 Cosmos Holdings Cosmos Holdings is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe. |  Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. |  Lee's Pharm Lee's Pharm (Lee's Pharmaceutical Holdings) is a company that develops, manufactures, and sells biopharmaceutical products for cardiovascular and infectious diseases areas. |  Sino Biopharmaceutical Sino Biopharmaceutical (中国生物制药) is a company engaged in the pharmaceutical manufacturing industry. |  Duopharma Biotech Duopharma Biotech is a pharmaceutical company that specializes in the manufacturing, research, development, and commercialization of generic drugs. | |
Founding Date | Founding Date N/A | Founding Date 2010 | Founding Date 1994 | Founding Date 1997 | Founding Date 1979 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Chicago, US HQ | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | Locations Hong Kong, HK HQ Taipei, TW | Locations Beijing, CN HQ Hong Kong, HK | Locations Bandar Baru Bangi, MY HQ Klang, MY Shah Alam, MY Quezon City, PH Singapore, SG |
Employees | Employees 6763% increase | Employees 44 | Employees 1,022 | Employees 24,379 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $65.3m (FY, 2025) | Revenue (est.) $8.3m (FY, 2020) | Revenue (est.) $1.4b (FY, 2024) | Revenue (est.) ¥31.8b (FY, 2025) | Revenue (est.) RM931.7m (FY, 2025) |
Cost of goods | Cost of goods $57.4m (FY, 2025) | Cost of goods N/A | Cost of goods $498.9m (FY, 2024) | Cost of goods ¥4.5b (FY, 2025) | Cost of goods RM513.5m (FY, 2025) |
Gross profit | Gross profit $7.9m (FY, 2025) | Gross profit N/A | Gross profit $961.4m (FY, 2024) | Gross profit ¥27.6b (FY, 2025) | Gross profit RM418.5m (FY, 2025) |
Net income | Net income ($19.1m) (FY, 2025) | Net income ($108.9m) (FY, 2020) | Net income $68.6m (FY, 2024) | Net income ¥5.3b (FY, 2025) | Net income RM87.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kadmon
HQ
New York, US
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
View companyLee's Pharm
HQ
Hong Kong, HK
Employees
1,022
Lee's Pharm (Lee's Pharmaceutical Holdings) is a company that develops, manufactures, and sells biopharmaceutical products for cardiovascular and infectious diseases areas.
View companySino Biopharmaceutical
HQ
Beijing, CN
Employees
24,379
Sino Biopharmaceutical (中国生物制药) is a company engaged in the pharmaceutical manufacturing industry.
View companyDuopharma Biotech
HQ
Bandar Baru Bangi, MY
Duopharma Biotech is a pharmaceutical company that specializes in the manufacturing, research, development, and commercialization of generic drugs.
View company